Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC
隐丹参酮是治疗与SFTPC基因BRICHOS结构域突变相关的间质性肺病的候选治疗药物。
期刊:iScience
影响因子:4.6
doi:10.1016/j.isci.2023.107731
Motoyasu Hosokawa,Ryuta Mikawa,Atsuko Hagiwara,Yukiko Okuno,Tomonari Awaya,Yuki Yamamoto,Senye Takahashi,Haruka Yamaki,Mitsujiro Osawa,Yasuhiro Setoguchi,Megumu K Saito,Shinji Abe,Toyohiro Hirai,Shimpei Gotoh,Masatoshi Hagiwara
